NCT06067880 is a clinical trial of Cancer-related Unilateral in Lymphedema, sponsored by Chang Gung Memorial Hospital.

Who is sponsoring NCT06067880?

NCT06067880 is sponsored by Chang Gung Memorial Hospital.

What drugs are being tested in NCT06067880?

Interventions in NCT06067880: Cancer-related Unilateral, Normal + Ectasis LVs.

What condition does NCT06067880 study?

NCT06067880 studies Lymphedema.

Is NCT06067880 still recruiting?

NCT06067880 is currently completed. Last updated 5 October 2023.

Last reviewed 2023-10-05 · How we verify

NCT06067880

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Surgical Intervention and Lymphatic Diseases.

Completed Last updated 5 October 2023

What this trial tests

trial testing Cancer-related Unilateral in Lymphedema in 83 participants. Completed in 1 September 2023.

Timeline

23 September 2022

Primary endpoint
10 March 2023

1 September 2023

Quick facts

Lead sponsor	Chang Gung Memorial Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	83
Start date	23 September 2022
Primary completion	10 March 2023
Estimated completion	1 September 2023
Sites	1 location across Taiwan

Drugs / interventions tested

Cancer-related Unilateral
Normal + Ectasis LVs

Conditions studied

Lymphedema — all drugs for Lymphedema →

Sponsor

Chang Gung Memorial Hospital

Who can join

Adults 20 to 90, any sex, with Lymphedema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Supermicrosurgical LVA has been proven effective in treating moderate to severe lymphedema, including cases with diffuse dermal backflow (DB) and even severe lymphatic fluid leakage. Therefore, the use of LVA should not be limited to mild lymphedema, and its indications should be expanded to become a primary surgical approach for more severe lymphedema cases. Among all surgical procedures for lymphedema, LVA is the least invasive, allowing for rapid recovery, minimizing the complications, and reducing medical costs.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparison of contraction-type and noncontraction-type lymphatic vessels in lymphaticovenous anastomosis for cancer-related unilateral lower limb lymphedema: a retrospective cohort propensity-score-matched outcome analysis.
Knoz M, Wang YM, Luo SD, Wu SC, et al · · 2024 · cited 4× · PMID 38265436 · DOI 10.1097/js9.0000000000001106

Verify or expand the search:

Other recruiting trials for Lymphedema

Currently open trials in the same condition.

NCT07489248 — Multimodal Ultrasound for Differentiating Lymphedema and Lipedema · recruiting
NCT07448467 — Investigation of the Effectiveness of Progressive Resistance Exercise Training in the Management of Lymphedema. · NA · recruiting
NCT02285868 — ATI Evidence-based Guide Investigating Clinical Services · active not recruiting
NCT07414615 — Aerobic Training in Lower Extremity Lymphedema · NA · recruiting
NCT06866197 — CONNECT: A Multi-Cohort, Prospective Investigation of the Symani® Surgical System · NA · recruiting

Other Chang Gung Memorial Hospital trials

Trials by the same sponsor.

NCT07419789 — Precision Care for Older Persons · NA · not yet recruiting
NCT07248345 — Virtual Reality Intervention for Family Caregivers of Persons Living With Dementia · NA · not yet recruiting
NCT07036978 — Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer · not yet recruiting
NCT07489833 — Metabolomic Pathways and Traditional Chinese Medicine Body Constitution in Cancer-related Fatigue · not yet recruiting
NCT07496528 — The ACURE Trial: Acupuncture for Colorectal Recovery · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06067880 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chang Gung Memorial Hospital
Last refreshed: 5 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06067880.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing